Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 24% ± 4% | |
ciliated cell | 3 studies | 22% ± 4% | |
astrocyte | 3 studies | 27% ± 7% |
Insufficient scRNA-seq data for expression of RNF43 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 94% | 1932.03 | 231 / 245 | 98% | 14.54 | 494 / 502 |
pancreas | 100% | 954.34 | 328 / 328 | 84% | 6.51 | 150 / 178 |
lung | 78% | 460.79 | 450 / 578 | 89% | 8.76 | 1023 / 1155 |
stomach | 75% | 603.85 | 268 / 359 | 84% | 37.69 | 239 / 286 |
liver | 87% | 853.81 | 196 / 226 | 63% | 7.02 | 254 / 406 |
intestine | 52% | 1283.61 | 503 / 966 | 93% | 47.48 | 490 / 527 |
breast | 58% | 668.26 | 266 / 459 | 75% | 7.86 | 838 / 1118 |
skin | 72% | 1583.37 | 1304 / 1809 | 55% | 4.59 | 261 / 472 |
adrenal gland | 100% | 2064.83 | 258 / 258 | 21% | 2.87 | 49 / 230 |
esophagus | 39% | 668.52 | 563 / 1445 | 80% | 8.87 | 147 / 183 |
kidney | 98% | 724.93 | 87 / 89 | 20% | 0.96 | 182 / 901 |
bladder | 48% | 423.86 | 10 / 21 | 68% | 18.44 | 343 / 504 |
thymus | 78% | 264.22 | 510 / 653 | 33% | 2.25 | 201 / 605 |
uterus | 29% | 132.66 | 49 / 170 | 71% | 6.10 | 328 / 459 |
tonsil | 0% | 0 | 0 / 0 | 98% | 8.47 | 44 / 45 |
ovary | 15% | 40.93 | 27 / 180 | 74% | 4.80 | 320 / 430 |
heart | 66% | 298.78 | 569 / 861 | 0% | 0 | 0 / 0 |
brain | 56% | 496.04 | 1479 / 2642 | 1% | 0.04 | 4 / 705 |
eye | 0% | 0 | 0 / 0 | 30% | 1.76 | 24 / 80 |
peripheral blood | 12% | 69.90 | 111 / 929 | 0% | 0 | 0 / 0 |
spleen | 4% | 11.41 | 10 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.31 | 1 / 29 |
adipose | 1% | 4.85 | 12 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 1% | 2.87 | 8 / 1335 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.26 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030178 | Biological process | negative regulation of Wnt signaling pathway |
GO_0016567 | Biological process | protein ubiquitination |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0016055 | Biological process | Wnt signaling pathway |
GO_0038018 | Biological process | Wnt receptor catabolic process |
GO_0072089 | Biological process | stem cell proliferation |
GO_0005635 | Cellular component | nuclear envelope |
GO_0005886 | Cellular component | plasma membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0005109 | Molecular function | frizzled binding |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | RNF43 |
Protein name | E3 ubiquitin-protein ligase RNF43 (EC 2.3.2.27) (RING finger protein 43) (RING-type E3 ubiquitin transferase RNF43) RING-type E3 ubiquitin transferase (EC 2.3.2.27) |
Synonyms | |
Description | FUNCTION: E3 ubiquitin-protein ligase that acts as a negative regulator of the Wnt signaling pathway by mediating the ubiquitination, endocytosis and subsequent degradation of Wnt receptor complex components Frizzled. Acts on both canonical and non-canonical Wnt signaling pathway . Along with RSPO2 and ZNRF3, constitutes a master switch that governs limb specification (By similarity). . |
Accessions | ENST00000584437.5 [Q68DV7-1] Q68DV7 ENST00000581868.1 ENST00000407977.7 [Q68DV7-1] ENST00000577716.5 [Q68DV7-1] ENST00000583753.5 [Q68DV7-2] J3KSE3 ENST00000577625.5 [Q68DV7-3] |